Integrated Diagnostics (LON:IDHC) Stock Price Down 7.6% – What’s Next?

Integrated Diagnostics Holdings plc (LON:IDHC)’s share price fell 7.6% during trading on Thursday . The company traded as low as GBX 0.53 and last traded at GBX 0.54. 1,043,812 shares traded hands during trading, an increase of 625% from the average session volume of 143,944 shares. The stock had previously closed at GBX 0.58.

Integrated Diagnostics Trading Down 8.6%

The stock has a market cap of £3.08 million, a PE ratio of 0.00, a price-to-earnings-growth ratio of 7.65 and a beta of 0.36. The company has a debt-to-equity ratio of 43.40, a quick ratio of 0.75 and a current ratio of 1.53. The company’s 50-day moving average price is GBX 0.59 and its 200 day moving average price is GBX 0.63.

Integrated Diagnostics Company Profile

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.